Arrowhead Pharmaceuticals to host R&D webinar on ARO-MAPT interim Phase 1/2a data

PUBT · 2d ago
Arrowhead Pharmaceuticals to host R&D webinar on ARO-MAPT interim Phase 1/2a data
  • Arrowhead Pharmaceuticals scheduled an R&D webinar for Oct. 14, 2026 at 11:30 a.m. PDT on ARO-MAPT interim Phase 1/2a data.
  • Webcast access, with replay, will be posted on the Events and Presentations page.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arrowhead Pharmaceuticals Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609290730BIZWIRE_USPR_____20260929_BW257404) on September 29, 2026, and is solely responsible for the information contained therein.